Direktorat Registrasi ObatValid

AMOXICILLIN

BPOM Number: GKL0823411338A1
Approved: 30 June 2026
Expiry: 30 June 2031
Form: SUSPENSI KERING

About This Registration

AMOXICILLIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0823411338A1. Its current registration status is Valid, with the licence valid until 30 June 2031. The product is registered to SAMPHARINDO PERDANA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 1 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: BOTOL @ 60 ML
Department: Direktorat Registrasi Obat
Data Last Updated: 1 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

SAMPHARINDO PERDANA - INDONESIA
KOTA SEMARANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

SAMPHARINDO PERDANA - INDONESIA
KOTA SEMARANG
primary
View profile →

Ingredients (1)

AMOXICILLIN TRIHYDRATE

Market Intelligence

Owner Portfolio: SAMPHARINDO PERDANA - INDONESIA holds 138 BPOM registrations
Manufacturer Scale: SAMPHARINDO PERDANA - INDONESIA produces 138 registered products
Registration Age: Registered for 2 months
Update Status: Recently updated (63 days ago)

FDA Cross-Reference

via openFDA

Generic Name: AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?